This 30-minute fireside chat focused on the development of vaccines for Alzheimer’s disease and other types of dementia. The conversation delved into crucial aspects such as the scientific foundations of Alzheimer’s vaccine development and the functional mechanisms of such a vaccine, and gave insights into development timelines and progress achieved so far.
We also explored the accessibility of vaccines, with special consideration given to low- and middle-income countries. It is crucial to ensure that access to the vaccine is not limited to specific regions or demographics, fostering a more inclusive approach to healthcare.
